Diapharm lays the foundations for future growth in the OTC industry in Europe: We offer licenses for innovative OTC products and dossiers with clear indications in line with regulatory requirements and with interesting strategic concepts.
We develop new, innovative OTC products for the European market. Our subsidiary red otc development often supports us in this process. For medicinal products, all marketing authorisation documents are available as CTD (common technical document) dossiers. For all OTC products, we can manage the necessary regulatory steps if required.
Fucus, 130 mg film-coated tablet
Newly registered in Germany & EU-wide roll-out potential:
herbal medicine for overweight patients
Capsella, 400 mg coated tablet
An OTC innovtion for the reduction of heavy menstrual bleeding
Achillea millefolium, 250 mg film-coated tablet
An OTC indication for the symptomatic treatment of minor spasm associated with menstrual periods (from 12 years)
Download the complete overview of all our available medicinal products, medical devices, food supplements and cosmetics here!
|Achillea millefolium (Yarrow)||250 mg||Film-coated tablet|
|Agnus castus (Chaste tree fruit)||4 mg||Film-coated tablet|
|Capsella (Shepherd's purse)||400 mg||Coated tablet|
|Cimicifuga (Black cohosh rhizome)||6.5 mg||Film-coated tablet|
|Hypericum + Cimicifuga (St. John's Wort herb + Black cohosh rhizome)||300 mg + 6.4 mg||Coated tablet|
|Passiflora (Passionflower herb)||425 mg||Coated tablet|
|Passiflora + Valeriana (Passionflower herb + Valerian root)||250 mg + 125 mg||Coated tablet|
|Valeriana (Valerian root)||450 mg||Coated tablet|
|Valeriana + Passiflora + Melissa (Valerian root + Melissa leaf + Passionflower herb)||125 mg + 112.5 mg + 80 mg||Coated tablet|